d(GC) - Association of Biotechnology and Pharmacy

Current Trends in Biotechnology and Pharmacy
Vol. 6 (2) 119-144 April 2012, ISSN 0973-8916 (Print), 2230-7303 (Online)
Table 1. Cumulative burden (%) of cancer deaths and incidence, and likelihood of survival by age group compared for less and more
developed countries. Raw data taken from IARC (16) and comparisons were performed using the GLOBOCAN Online Analysis - Age-Specific
Tables tools, using Population as Less Developed, More Developed or Panama; Sex as Both Sexes; Data Type as Incidence or Mortality; and
Statistic as Numbers. ‘Deaths’ and ‘Incidence’ expressed as the cumulative percentage of deaths (or incidences) occurring due to cancer in
defined age groups. ‘Crude likelihood of survival’ calculated as [1-total number of deaths/total number of incidences]. Relative likelihood of
survival calculated as [Crude likelihood of survival for Less developed countries or Panama/Crude likelihood of survival for More developed
countries].
Deaths Incidence Crude likelihood Relative likelihood
of survival of survival
Age Less More Less More Less More Less
developed developed Panama developed developed Panama developed developed Panama developed Panama
0-14 1.9 0.2 1.9 2.1 0.5 2.9 0.36 0.80 0.53 0.45 0.66
15-39 9.4 1.8 8.3 12.1 4.5 12.0 0.47 0.79 0.52 0.59 0.66
40-44 14.1 3.2 11.2 18.3 7.3 16.2 0.46 0.72 0.52 0.64 0.72
45-49 20.4 6.3 15.2 26.1 11.9 21.0 0.42 0.66 0.42 0.64 0.64
50-54 29.5 11.6 20.8 36.5 18.9 27.1 0.38 0.60 0.37 0.63 0.62
55-59 40.8 19.9 29.2 48.7 28.8 36.0 0.34 0.56 0.35 0.61 0.63
60-64 52.0 29.7 38.7 60.1 40.3 46.1 0.30 0.55 0.35 0.55 0.64
65-69 64.3 42.2 50.2 71.8 53.5 58.3 0.25 0.51 0.35 0.49 0.69
70-74 77.6 57.2 63.3 83.3 68.2 71.5 0.18 0.46 0.31 0.39 0.67
75+ 100.0 100.0 100.0 100.0 100.0 100.0 0.05 0.29 0.11 0.17 0.38
Rebecca E. Smith and Juan Miguel Pascale
122